Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IL-6 | 100 | ug/mL | 1 | TRAIL | 44.0 | 58 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | TRAIL | 41.0 | 60 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TRAIL | 36.0 | 65 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TRAIL | 41.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TRAIL | 37.5 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | TRAIL | 40.0 | 48 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | TRAIL | 50.5 | 52 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | TRAIL | 31.0 | 67 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 26.0 | 73 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 27.0 | 63 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 27.0 | 85 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 30.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 31.0 | 73 | |
N2586 | IL-17A | 100 | ng/mL | 1 | TRAIL | 51.5 | 38 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 42.0 | 41 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 48.0 | 35 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 43.0 | 47 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 34.5 | 48 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | TRAIL | 47.0 | 57 | |
RA2159 | 1 | TRAIL | 25.5 | 38 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | TRAIL | 37.0 | 90 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | TRAIL | 30.0 | 54 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | TRAIL | 24.0 | 65 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | TRAIL | 27.5 | 78 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | TRAIL | 29.0 | 60 |